These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15312212)

  • 1. Statistics review 11: assessing risk.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Aug; 8(4):287-91. PubMed ID: 15312212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting measures of treatment effect.
    Davies HT
    Hosp Med; 1998 Jun; 59(6):499-501. PubMed ID: 9775281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk and odds--how to calculate with events].
    Malmquist J
    Lakartidningen; 2002 Feb; 99(8):751-3, 756. PubMed ID: 11894612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.
    Localio AR; Margolis DJ; Berlin JA
    J Clin Epidemiol; 2007 Sep; 60(9):874-82. PubMed ID: 17689803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome.
    Bajwa EK; Yu CL; Gong MN; Thompson BT; Christiani DC
    Crit Care Med; 2007 May; 35(5):1290-5. PubMed ID: 17414088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation measures in epidemiology].
    Ollivier L; Michel R; Spiegel A; Boutin JP
    Med Trop (Mars); 2003; 63(1):75-8. PubMed ID: 12891755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calculation of sample size for the detection of relative risk with a predetermined confidence level and power].
    Bernard PM; Lapointe C
    Rev Epidemiol Sante Publique; 1990; 38(3):255-60. PubMed ID: 2396039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to practice evidence-based medicine.
    Donald A
    MedGenMed; 2003 Jan; 5(1):27. PubMed ID: 12827088
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding measures of treatment effect in clinical trials.
    Akobeng AK
    Arch Dis Child; 2005 Jan; 90(1):54-6. PubMed ID: 15613512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
    Rücker G; Schwarzer G; Carpenter J; Olkin I
    Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative risks and odds ratios: what's the difference?
    Last A; Wilson S
    J Fam Pract; 2004 Feb; 53(2):108. PubMed ID: 14764292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk and prevention in cardiovascular diseases].
    Gulácsi L; Edes I; Hajdú E; Tóthfalusi L
    Orv Hetil; 2004 Dec; 145(50):2515-21. PubMed ID: 15662751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stroke--possibilities for prevention].
    Kolominsky-Rabas P
    Biomed Tech (Berl); 2005; 50(7-8):233-7. PubMed ID: 16117437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
    Abou Diwan CH; Oghlakian GO; Antonios SI; Otrock ZK; Rebeiz AG
    J Med Liban; 2004; 52(1):39-47. PubMed ID: 15881701
    [No Abstract]   [Full Text] [Related]  

  • 16. The relative merits of risk ratios and odds ratios.
    Cummings P
    Arch Pediatr Adolesc Med; 2009 May; 163(5):438-45. PubMed ID: 19414690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to measure the benefits of preventive interventions. The Italian Group for Evidence-Based Medicine (GIMBE)].
    Cartabellotta A; Notarbartolo A
    Epidemiol Prev; 1997; 21(3):174-9. PubMed ID: 9424433
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding systematic reviews and meta-analysis.
    Akobeng AK
    Arch Dis Child; 2005 Aug; 90(8):845-8. PubMed ID: 16040886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concepts important in the interpretation of therapeutic studies. Absolute risk reduction (ARR), relative risk reduction (RRR), number needed to treat (NNT)].
    Steurer J
    Praxis (Bern 1994); 1997 Apr; 86(15):614. PubMed ID: 9213913
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved estimates of floating absolute risk.
    Plummer M
    Stat Med; 2004 Jan; 23(1):93-104. PubMed ID: 14695642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.